Research ArticleArticle
Longterm Survival Among Patients with Scleroderma-associated Pulmonary Arterial Hypertension Treated with Intravenous Epoprostenol
David B. Badesch, Michael D. McGoon, Robin J. Barst, Victor F. Tapson, Lewis J. Rubin, Fredrick M. Wigley, Kenneth M. Kral, Ibrahim H. Raphiou and Glenn D. Crater
The Journal of Rheumatology September 2009, jrheum.081277; DOI: https://doi.org/10.3899/jrheum.081277
David B. Badesch
Michael D. McGoon
Robin J. Barst
Victor F. Tapson
Lewis J. Rubin
Fredrick M. Wigley
Kenneth M. Kral
Ibrahim H. Raphiou
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Longterm Survival Among Patients with Scleroderma-associated Pulmonary Arterial Hypertension Treated with Intravenous Epoprostenol
David B. Badesch, Michael D. McGoon, Robin J. Barst, Victor F. Tapson, Lewis J. Rubin, Fredrick M. Wigley, Kenneth M. Kral, Ibrahim H. Raphiou, Glenn D. Crater
The Journal of Rheumatology Sep 2009, jrheum.081277; DOI: 10.3899/jrheum.081277
Longterm Survival Among Patients with Scleroderma-associated Pulmonary Arterial Hypertension Treated with Intravenous Epoprostenol
David B. Badesch, Michael D. McGoon, Robin J. Barst, Victor F. Tapson, Lewis J. Rubin, Fredrick M. Wigley, Kenneth M. Kral, Ibrahim H. Raphiou, Glenn D. Crater
The Journal of Rheumatology Sep 2009, jrheum.081277; DOI: 10.3899/jrheum.081277